Osteoporosis is defined as a systemic skeletal disease characterized by low bone mass and microarchitectural deterioration of bone tissue, with a consequent increase in bone fragility and susceptibility to fracture. Osteoporosis is of two different types, primary and secondary.
The causes of osteoporosis include hyperparathyroidism, hyperglycemia, medications, smoking, alcohol use, oxidative stress, inflammation, calcium-deficient, menopause, etc. The most common symptoms of osteoporosis is a vertebral compression fracture or hip fracture. The compression fractures in the spine, caused by weakened vertebrae can lead to pain in the mid-back area. The fractures often stabilize on their own, and the pain goes away, but sometimes the pain persists because the crushed bone continues to move around and break. The symptoms include loss of height, back pain, increased number of bed days, depression, etc.
In terms of diagnosis, The National Osteoporosis Foundation, the American Medical Association, and other major medical organizations recommend a dual-energy X-ray absorptiometry scan (DXA, formerly known as DEXA) can be used to detect the occurrence of osteoporosis accurately. Osteoporosis is also diagnosed using bone density measurements of the lumbar spine and proximal femur.
Get FREE sample copy at:
https://www.delveinsight.com/sample-request/post-menopausal-osteoporosis-market
The Post Menopausal Osteoporosis market report also covers emerging drugs, current treatment practices, Post Menopausal Osteoporosis market share of the individual therapies, current and forecasted Post Menopausal Osteoporosis Market Size from 2017 to 2030 segmented by seven major markets.
The report provides a detailed current Post Menopausal Osteoporosis treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses the underlying potential of the market.
Post Menopausal Osteoporosis Market Key Facts
As per the study conducted by Tian et al., titled “Prevalence of osteoporosis and related lifestyle and metabolic factors of postmenopausal women and elderly men” wherein, the reported prevalence of osteoporosis in women was 9% in the United Kingdom, 15% in France and Germany, 16% in the USA, and 38% in Japan. The prevalence of osteoporosis in the whole participants was 9.65% for postmenopausal women and 8.08% for elderly men.
According to a study conducted by Bolster et al. titled “Osteoporosis” states that about 8 million women and 2 million men in the United States have osteoporosis. In addition, more than 95% in women and about 80% in men is primary osteoporosis. Whereas, secondary osteoporosis is less than 5% in women and about 20% in men.
As per the study conducted by Darba et al. titled “Cost-utility of denosumab for the treatment of postmenopausal osteoporosis in Spain,” found the prevalence rate of postmenopausal osteoporosis (PMO) of approximately 25% for women aged 60–69 years and 40% for those aged 70–79 years was in Spain.
Key Benefits of Post Menopausal Osteoporosis Market Report
-
Post Menopausal Osteoporosis market report provides an in-depth analysis of Post Menopausal Osteoporosis Market Size, Share, Trend, Epidemiology and Market Forecast till 2030, in 7 major market i.e. EU5 (Germany, Italy, Spain, France and the UK), Japan, and the United States.
-
The Post Menopausal Osteoporosis market report will help in developing business strategies by understanding the Post Menopausal Osteoporosis Market trends & developments, key players and future market competition that will shape and drive the Post Menopausal Osteoporosis market in the upcoming years.
-
The Post Menopausal Osteoporosis market report covers Post Menopausal Osteoporosis current treatment practices, emerging drugs, market share of the individual therapies in 7 MM.
-
The report provides a detailed assessment of the Post Menopausal Osteoporosis market in terms of market drivers & barriers, Unmet Needs, market opportunities, patient population, comparative analysis of pipeline products with detailed clinical profiles, and other factors.
Post Menopausal Osteoporosis Market
Post Menopausal Osteoporosis market size is expected to increase during the forecast period owing to the rise in the number of prevalent cases in the 7MM.
The Post Menopausal Osteoporosis market outlook section of the report helps to build the detailed comprehension of the historic, current and forecasted Post Menopausal Osteoporosis market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand for better technology.
The report gives a thorough detail of Post Menopausal Osteoporosis market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, and view of the key opinion leaders.
Post Menopausal Osteoporosis Epidemiology
The Post Menopausal Osteoporosis epidemiology section covers insights about historical and current Post Menopausal Osteoporosis patient pool and forecasted trends for every seven major countries (i.e. the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2017 to 2030.
It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.
Post Menopausal Osteoporosis Drugs Uptake and Key Market Players
The Post Menopausal Osteoporosis Drugs Uptake section focuses on the rate of uptake of the potential drugs recently launched in the Post Menopausal Osteoporosis market or expected to get launched in the market during the study period. The analysis covers Post Menopausal Osteoporosis market uptake by drugs; patient uptake by therapies; and sales of each drug.
Report’s Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.
The key companies in Post Menopausal Osteoporosis Market include:
Sandoz
Haoma Medica
Amgen
Pfizer
Radius Health
Eli Lilly
And others.
Post Menopausal Osteoporosis therapies covered in the report include:
Forteo (Teriparatide)
Fablyn (Lasofoxifene)
Tymlos (abaloparatide)
Denosumab (GP2411)
NaQuinate
And many others.
Table of Content
1. Key Insights
2. Executive Summary
3. Post Menopausal Osteoporosis Competitive Intelligence Analysis
4. Post Menopausal Osteoporosis Market Overview at a Glance
5. Post Menopausal Osteoporosis Disease Background and Overview
6. Post Menopausal Osteoporosis Patient Journey
7. Post Menopausal Osteoporosis Epidemiology and Patient Population
8. Post Menopausal Osteoporosis Treatment Algorithm, Current Treatment, and Medical Practices
9. Post Menopausal Osteoporosis Unmet Needs
10. Key Endpoints of Post Menopausal Osteoporosis Treatment
11. Post Menopausal Osteoporosis Marketed Products
12. Post Menopausal Osteoporosis Emerging Therapies
13. Post Menopausal Osteoporosis Seven Major Market Analysis
14. Attribute Analysis
15. Post Menopausal Osteoporosis Market Outlook (7 major markets)
16. Post Menopausal Osteoporosis Access and Reimbursement Overview
17. KOL Views on the Post Menopausal Osteoporosis Market.
18. Post Menopausal Osteoporosis Market Drivers
19. Post Menopausal Osteoporosis Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
Related Reports
Post Menopausal Osteoporosis Epidemiology Forecast
DelveInsight's Post Menopausal Osteoporosis - Epidemiology Forecast 2030 report delivers an in-depth understanding of the disease, historical, and forecasted epidemiology of Post Menopausal Osteoporosis in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.
Post Menopausal Osteoporosis Pipeline Insights
Post Menopausal Osteoporosis Pipeline Insight, 2020 report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Post Menopausal Osteoporosis market
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end to end comprehensive solutions to improve their performance.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email:Send Email
Phone: +919650213330
Address:304 S. Jones Blvd. 2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/
